594 related articles for article (PubMed ID: 26752023)
1. Induction of mucosal immunity through systemic immunization: Phantom or reality?
Su F; Patel GB; Hu S; Chen W
Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of mucosal adjuvants and immunization routes for the induction of systemic and mucosal humoral immune responses in macaques.
Veazey RS; Siddiqui A; Klein K; Buffa V; Fischetti L; Doyle-Meyers L; King DF; Tregoning JS; Shattock RJ
Hum Vaccin Immunother; 2015; 11(12):2913-22. PubMed ID: 26697975
[TBL] [Abstract][Full Text] [Related]
3. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
Zeng L; Liu Y; Wang H; Liao P; Song Z; Gao S; Wu Y; Zhang X; Yin Y; Xu W
Vaccine; 2015 Feb; 33(8):1008-16. PubMed ID: 25595867
[TBL] [Abstract][Full Text] [Related]
4. Mucosal vaccines: Strategies and challenges.
Li M; Wang Y; Sun Y; Cui H; Zhu SJ; Qiu HJ
Immunol Lett; 2020 Jan; 217():116-125. PubMed ID: 31669546
[TBL] [Abstract][Full Text] [Related]
5. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
[TBL] [Abstract][Full Text] [Related]
6. Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity.
Rochereau N; Pavot V; Verrier B; Jospin F; Ensinas A; Genin C; Corthésy B; Paul S
J Allergy Clin Immunol; 2016 Jan; 137(1):214-222.e2. PubMed ID: 26414879
[TBL] [Abstract][Full Text] [Related]
7. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
Campo JD; Zayas C; Romeu B; Acevedo R; González E; Bracho G; Cuello M; Cabrera O; Balboa J; Lastre M
Methods; 2009 Dec; 49(4):301-8. PubMed ID: 19410000
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
Rodríguez A; Rottenberg M; Tjärnlund A; Fernández C
Scand J Immunol; 2006 Mar; 63(3):177-83. PubMed ID: 16499570
[TBL] [Abstract][Full Text] [Related]
10. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.
Czerkinsky C; Holmgren J
Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117
[TBL] [Abstract][Full Text] [Related]
11. Mucosal vaccine design and delivery.
Woodrow KA; Bennett KM; Lo DD
Annu Rev Biomed Eng; 2012; 14():17-46. PubMed ID: 22524387
[TBL] [Abstract][Full Text] [Related]
12. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
Gupta NK; Tomar P; Sharma V; Dixit VK
Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
[TBL] [Abstract][Full Text] [Related]
13. Routing dependent immune responses after experimental R848-adjuvated vaccination.
van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
[TBL] [Abstract][Full Text] [Related]
14. Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.
Srivastava A; Gowda DV; Madhunapantula SV; Shinde CG; Iyer M
APMIS; 2015 Apr; 123(4):275-88. PubMed ID: 25630573
[TBL] [Abstract][Full Text] [Related]
15. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
16. Vaccines, adjuvants and key factors for mucosal immune response.
Correa VA; Portilho AI; De Gaspari E
Immunology; 2022 Oct; 167(2):124-138. PubMed ID: 35751397
[TBL] [Abstract][Full Text] [Related]
17. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
[TBL] [Abstract][Full Text] [Related]
18. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
Boyaka PN
J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
Henderson A; Propst K; Kedl R; Dow S
Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]